The EoE-centered framework supports disease modeling, multidimensional efficacy endpoints, type 2 biomarker analysis, and cross-indication translational research ...
Morning Overview on MSN
Scientists are racing to build a post-Ozempic drug without the nausea and weight regain
Patients who stop taking semaglutide regain most of the weight they lost within a year, and the nausea that comes with ...
Morning Overview on MSN
Weight-loss drugs delivered big results but left doctors with big unanswered questions
Semaglutide and tirzepatide have produced some of the largest weight reductions ever recorded in clinical trials, with losses ...
University of Louisville researchers have discovered how a naturally occurring microbial compound may help protect the gut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results